Cargando…

Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?

Detalles Bibliográficos
Autor principal: Riera, Celine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889048/
https://www.ncbi.nlm.nih.gov/pubmed/33604590
http://dx.doi.org/10.33696/diabetes.1.028
_version_ 1783652234953752576
author Riera, Celine E
author_facet Riera, Celine E
author_sort Riera, Celine E
collection PubMed
description
format Online
Article
Text
id pubmed-7889048
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-78890482021-02-17 Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes? Riera, Celine E J Diabetes Clin Res Article 2020 /pmc/articles/PMC7889048/ /pubmed/33604590 http://dx.doi.org/10.33696/diabetes.1.028 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Riera, Celine E
Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title_full Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title_fullStr Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title_full_unstemmed Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title_short Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
title_sort can monoclonal antibodies against cgrp offer new treatment options for type 2 diabetes?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889048/
https://www.ncbi.nlm.nih.gov/pubmed/33604590
http://dx.doi.org/10.33696/diabetes.1.028
work_keys_str_mv AT rieracelinee canmonoclonalantibodiesagainstcgrpoffernewtreatmentoptionsfortype2diabetes